Mettler-Toledo International Inc. (MTD) SEC Filings & Earnings Calls
EquiReason read 12 Mettler-Toledo International Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-03 — Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update).
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 33.5B
- P/E TTM
- 37.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
31 Jul 202610-QMettler-Toledo reported Q2 2026 revenue of $1.027B (+4.5% YoY) and net income of $232.9M (+15.1% YoY), with a one-time tariff refund benefit.earningsopen
Figures in the filing · each found in the filing text
| Total net sales · Q2-2026 | $1.03B | +4% y/y |
| Net earnings · Q2-2026 | $233M | +15% y/y |
| Gross profit · Q2-2026 | $650M | +12% y/y |
| Diluted earnings per common share · Q2-2026 | $11.55 | +18% y/y |
| Operating cash flow · H1-2026 | $450M | +5% y/y |
| Free cash flow · H1-2026 | $405M | +4% y/y |
| Laboratory sales · Laboratory · Q2-2026 | $553M | +3% y/y |
| Industrial sales · Industrial · Q2-2026 | $418M | +6% y/y |
| Retail sales · Retail · Q2-2026 | $57M | +13% y/y |
| Americas sales · Americas · Q2-2026 | $402M | -3% y/y |
Risks flagged
Tariff-related customer refunds
“tariff-related customer refunds of $27.8 million that reduced net sales” · word for word
U.S. revenue decline
“U.S. Operations $352,477 vs $372,516 for three months ended June 30, 2026 and 2025, respectively.”
30 Jul 20268-K · 2.02Reported sales $1.03B (+4% y/y); GAAP EPS $11.55 (+18% y/y); Adjusted EPS $11.46 (+14% y/y); Guidance: FY2026 Adjusted EPS guidance raised to $47.15-$47.50 from $46.30-$46.95; local currency sales growth 4-5%earningsopen
Figures in the filing · each found in the filing text
| Reported sales · Q2-2026 | $1.03B | +4% y/y |
| GAAP EPS · Q2-2026 | $11.55 | +18% y/y |
| Adjusted EPS · Q2-2026 | $11.46 | +14% y/y |
| Adjusted Operating Profit · Q2-2026 | $309M | +9% y/y |
| Full-year 2026 Adjusted EPS guidance · FY2026 | $47.33 |
Guidance
FY2026 Adjusted EPS guidance raised to $47.15-$47.50 from $46.30-$46.95; local currency sales growth 4-5%
Raised full-year Adjusted EPS guidance due to strong Q2 performance and improved market conditions. Local currency sales growth guidance maintained.
Risks flagged
Tariff impact: One-time IEEPA tariff refunds of $52M benefited cost of sales, with $28M refunded to customers, reducing net sales. Future tariff policy remains uncertain.
“one-time $52 million benefit from IEEPA tariff refunds that benefited Cost of Sales, as well as a one-time $28 million related refund to customers that reduced Net Sales” · word for word
8 May 202610-QTotal net sales $947M (+7% y/y); Net earnings $169M (+4% y/y); Net cash provided by operating activities $140M (-28% y/y)open
Figures in the filing · each found in the filing text
| Total net sales · Q1-2026 | $947M | +7% y/y |
| Net earnings · Q1-2026 | $169M | +4% y/y |
| Net cash provided by operating activities · Q1-2026 | $140M | -28% y/y |
| Product revenue · Q1-2026 | $684M | +5% y/y |
| Service revenue · Q1-2026 | $263M | +12% y/y |
| Americas revenue · Q1-2026 | $389M | +3% y/y |
| Europe revenue · Q1-2026 | $279M | +12% y/y |
| Asia / Rest of World revenue · Q1-2026 | $279M | +8% y/y |
| Laboratory sales · Q1-2026 | $525M | +5% y/y |
| Industrial sales · Q1-2026 | $375M | +10% y/y |
Risks flagged
Tariff refund uncertainty
“These potential refunds represent gain contingencies under ASC 450-30 and have not been recognized in the financial statements for the three months ended March 31, 2026 as uncertainties remain regarding government approval and appeals and final liquidation amounts.” · word for word
Customer refund obligation
“The Company anticipates that a significant portion of any refund received from the U.S. government will be refunded to its customers.” · word for word
18 Mar 2026DEF 14AAnnual proxy statement disclosing executive compensation, governance, and financial performance for 2025.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $3.89B | |
| Net Income · FY2025 | $869M | |
| Adjusted Non-GAAP Earnings Per Share · FY2025 | $42.89 | +4% y/y |
| Net Cash Flow · FY2025 | $1.04B |
Risks flagged
Currency Fluctuation Risk
“Sales targets are set at budgeted currency rates, indicating exposure to FX volatility.”
Trade Dispute Impact
“the Compensation Committee approved a one-time, modest adjustment, applicable to all employees who participate in the company’s POBS annual cash incentive plans, to partially offset the impact of international trade disputes.” · word for word
6 Feb 202610-KNet sales $4.00B (+4% y/y); Gross profit margin 59.4; Operating cash flow $956M (-1% y/y); Guidance: 2026 capex ~$130M; 2026 share repurchases $825M-$875Mopen
Figures in the filing · each found in the filing text
| Net sales · FY2025 | $4.00B | +4% y/y |
| Gross profit margin · FY2025 | 59.4% | |
| Operating cash flow · FY2025 | $956M | -1% y/y |
| Capital expenditures · FY2025 | $107M | +3% y/y |
| Share repurchases · FY2025 | $800M | -6% y/y |
| Total debt · 2025-12-31 | $2.15B | |
| U.S. Operations net sales to external customers · U.S. Operations · FY2025 | $1.50B | +5% y/y |
| Chinese Operations net sales to external customers · Chinese Operations · FY2025 | $635M | +1% y/y |
Guidance
2026 capex ~$130M; 2026 share repurchases $825M-$875M
Management expects continued soft demand but plans higher capex and share repurchases, with tariff mitigation actions expected to fully offset current tariffs in 2026.
Risks flagged
Tariff cost pressure on gross margin
“We estimate that we incurred costs before mitigation actions from the 2025 incremental tariffs of approximately $50 million in 2025” · word for word
End-market demand uncertainty
“In 2025, we experienced soft market demand in our end markets.” · word for word
Currency exposure
“We estimate a 1% strengthening of the Swiss franc against the euro would reduce our earnings before tax by approximately $2.8 million to $3.1 million annually.” · word for word
5 Feb 20268-K · 2.02Reported sales $1.13B (+8% y/y); Adjusted EPS $13.36 (+8% y/y); GAAP EPS $13.98 (+17% y/y); Guidance: FY2026 adjusted EPS guidance raised to $46.05-$46.70 from $45.35-$46.00earningsopen
Figures in the filing · each found in the filing text
| Reported sales · Q4-2025 | $1.13B | +8% y/y |
| Adjusted EPS · Q4-2025 | $13.36 | +8% y/y |
| GAAP EPS · Q4-2025 | $13.98 | +17% y/y |
| Full year reported sales · FY2025 | $4.03B | +4% y/y |
| Full year adjusted EPS · FY2025 | $42.73 | +4% y/y |
| Full year GAAP EPS · FY2025 | $42.05 | +4% y/y |
Guidance
FY2026 adjusted EPS guidance raised to $46.05-$46.70 from $45.35-$46.00
MTD raised FY2026 adjusted EPS guidance by ~2% at midpoint, citing broad-based growth and strategic positioning. Q4 results beat with 8% sales growth and 8% adjusted EPS growth.
Risks flagged
Global trade disputes and soft market conditions pose ongoing risks to demand.
“successfully navigated challenges posed by global trade disputes and soft market conditions” · word for word
7 Nov 202510-QMettler-Toledo reported Q3 2025 net sales of $1.03B, up 7.9% YoY, with net earnings of $217.5M, up 2.8% YoY.earningsopen
Figures in the filing · each found in the filing text
| Total net sales · Q3-2025 | $1.03B | +8% y/y |
| Net earnings · Q3-2025 | $217M | +3% y/y |
| Free cash flow · 9M-2025 | $665M | +4% y/y |
| Operating cash flow · 9M-2025 | $730M | +4% y/y |
| Product revenue · Q3-2025 | $767M | +7% y/y |
| Service revenue · Q3-2025 | $263M | +10% y/y |
| Americas revenue · Americas · Q3-2025 | $432M | +10% y/y |
| Europe revenue · Europe · Q3-2025 | $293M | +13% y/y |
| Asia/Rest of World revenue · Asia/Rest of World · Q3-2025 | $305M | +2% y/y |
| Laboratory revenue · Laboratory · Q3-2025 | $565M | +6% y/y |
Risks flagged
China demand slowdown
“China operations revenue grew only 1.6% YoY in Q3 2025.”
Swiss Operations decline
“Swiss Operations revenue declined 2.6% YoY in Q3 2025.”
Gross margin pressure
“Gross margin decreased from 60.0% to 59.2% YoY in Q3 2025.”
6 Nov 20258-K · 2.02Reported sales $1.03B (+8% y/y); EPS $10.57 (+6% y/y); Adjusted EPS $11.15 (+9% y/y); Guidance: FY2025 adjusted EPS raised to $42.05-42.25 from $41.70-42.20earningsopen
Figures in the filing · each found in the filing text
| Reported sales · Consolidated · Q3-2025 | $1.03B | +8% y/y |
| EPS · Consolidated · Q3-2025 | $10.57 | +6% y/y |
| Adjusted EPS · Consolidated · Q3-2025 | $11.15 | +9% y/y |
| Adjusted Operating Profit · Consolidated · Q3-2025 | $310M | +4% y/y |
| FY2025 Adjusted EPS guidance · Consolidated · FY2025 | $42.15 |
Guidance
FY2025 adjusted EPS raised to $42.05-42.25 from $41.70-42.20
Raised FY2025 guidance on strong Q3 results and positive outlook. Q4 and FY2026 guidance also provided, indicating confidence in sustained growth.
Risks flagged
Tariff headwinds expected to impact margins: 7% gross headwind in Q4, 5% for FY2025.
“Estimated 7% gross headwind to Adjusted EPS growth due to higher tariff costs. Additional 5% gross headwind from higher tariff costs for full year.” · word for word
Global trade disputes and governmental policy uncertainties could impact future performance.
“We face several uncertainties in global trade disputes and governmental policies.” · word for word
Shipping delays from Q4 2023 benefiting Q1 2024 create a 1.5% headwind to FY2025 local currency sales growth.
“Headwind of approximately 1.5% from the previously disclosed shipping delays in the fourth quarter of 2023.” · word for word
Mettler-Toledo International Inc. — questions
- What did Mettler-Toledo International Inc. file recently?
- 12 SEC filings in the last 12 months. Latest: 8-K on 2026-08-03 — Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)
Every figure on this page comes from Mettler-Toledo International Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.